QuidelOrtho (QDEL) EBITDA (2021 - 2026)

QuidelOrtho has disclosed EBITDA across 6 years of filings, most recently posting -$80.5 million for Q1 2026.

• EBITDA for Q1 2026 came in at -$80.5 million, down 26733.33% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (down 234.33% YoY), and the FY2025 annual result was -$1.1 billion, up 46.02% from the prior year.
• EBITDA came in at -$80.5 million for Q1 2026 at QuidelOrtho, up from -$126.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $620.7 million in Q2 2022 to a low of -$1.7 billion in Q1 2024.
• The 5-year median for EBITDA is -$10.2 million (2023), against an average of -$124.0 million.
• Across the five-year window, EBITDA surged 242.06% in 2022 and tumbled 64175.0% in 2025, its largest moves.
• QuidelOrtho's EBITDA stood at $56.8 million in 2022, then sank by 46.83% to $30.2 million in 2023, then sank by 799.01% to -$211.1 million in 2024, then soared by 40.12% to -$126.4 million in 2025, then surged by 36.31% to -$80.5 million in 2026.
• The last three EBITDA figures came in at -$80.5 million (Q1 2026), -$126.4 million (Q4 2025), and -$768.9 million (Q3 2025), per Business Quant data.